Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 8,000 shares at $69.00 ($552K) on 2024-03-18, disclosed to the SEC on 2024-03-20.
Scheduled sale ($552k) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.00 | 7,764 | $536K | 97.0% |
| 2 | $69.64 | 236 | $16K | 3.0% |
| Total | $69.02 avg | 8,000 | $552K | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |